Pre-market Hot Trades in US Stocks
Destiny Tech100 is up 7.33% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 15, the global financial and trade environment is facing structural adjustments, and companies need to respond flexibly to maintain competitiveness. This dynamic may affect market sentiment and drive up the price of Destiny Tech100. Source: Zhitong Finance
</li>
<li>
On December 15, Tesla's early supporter Ross Gerber turned bearish, criticizing Musk's distractions from his diverse ventures affecting the company's performance. This news may impact the overall sentiment in tech stocks, indirectly pushing up the price of Destiny Tech100. Source: Zhitong Finance
</li>
<li>
On December 15, the ongoing global DRAM shortage continues to affect the smartphone market, forcing manufacturers to adjust their product strategies. This supply chain challenge may lead to a rise in related tech stocks, pushing up the price of Destiny Tech100. Source: Zhitong Finance The competition in the tech industry is intensifying, and the flow of funds is uncertain.
</li>
</ol>
Astera Labs is up 3.65% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 15, Astera Labs' Q3 update shows its market potential is expanding, designs are gaining visibility, R&amp;D investments are recovering, early Scorpio X production and optical roadmap are credible. While these developments do not eliminate long-term risks, they reduce uncertainty for further declines, supporting the rise in stock price.
</li>
<li>
On December 15, analysts upgraded Astera Labs' rating from sell to hold, believing that the risk-reward asymmetry has significantly changed, with corrections reducing risks and updates supporting returns, driving up the stock price.
</li>
<li>
On December 14, market attention on Astera Labs increased, and although analysts believe there are better investment options, Astera Labs still received a moderate buy rating, with positive market sentiment. The tech industry has performed strongly recently, with significant capital inflows.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Agape ATP is up 55.44% in pre-market trading. Based on recent news:
<ol>
<li>
On December 17, Agape ATP announced it will continue to focus on diversifying its health and wellness and sustainable green energy businesses to provide sustainable shareholder value. This news boosted investor confidence, driving up the stock price.
</li>
<li>
On December 17, despite third-quarter revenue falling from $465,500 in the second quarter to $370,590, the loss per share remained unchanged at $0.01. Despite poor financial performance, market expectations for the company's future development remain optimistic.
</li>
<li>
On December 17, Benzinga's Edge stock rankings show that ATPC stock has negative price trends across all time frames. However, recent business diversification plans may change this trend. The health and wellness and sustainable energy sectors have been active recently
Direct Digital pre-market rose 50.76%, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
</li>
</ol>
Aditxt pre-market rose 42.96%. Based on recent key news:
<ol>
<li>
On December 17, Aditxt's stock price rose 42.96% in pre-market trading, mainly due to market attention on its recent performance. Although the stock price has dropped 99.97% year-to-date, the significant pre-market increase indicates a reassessment of its future potential by investors. According to Benzinga data, Aditxt's market trend remains negative, but short-term price fluctuations have sparked market interest.
</li>
<li>
On December 15, Aditxt announced a $20 million financing plan, leading to a drop in stock price. This move was interpreted by the market as the company seeking funds to support its business development. Although it puts pressure on the stock price in the short term, it may help the company's strategic implementation in the long run.
</li>
<li>
Recently, Aditxt's market capitalization was only $794,410, indicating a low valuation status in the market. Investors may see the current price as a potential investment opportunity, although risks still exist. The biotechnology industry is experiencing increased volatility, requiring caution
</li>
</ol>

DXYZ

ALAB

Destiny Tech100 pre-market up 7.33%; Astera Labs pre-market up 3.65%; Agape ATP pre-market up 55.44%; Direct Digital pre-market up 50.76%; Aditxt pre-market up 42.96%

Pre-market hot trades in US stocks: Destiny Tech100 up 7.33% in pre-market; Astera Labs up 3.65% in pre-market